Of note, mutations in several of the genes that confer leukemia predisposition (e.g., CEBPA, ETV6, GATA2, NF1, RUNX1, PTPN11, CBL, and RAS) are also frequently found in sporadic acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) (Cancer Genome Atlas Research Network et al., 2013). This evidence concerns the gene GATA2 and myelodysplastic syndrome.